Skip to main content

Table 3 Characteristics of spontaneous reports in the GlaxoSmithKline Vaccines spontaneous report database, by vaccine

From: Use of Logistic Regression to Combine Two Causality Criteria for Signal Detection in Vaccine Spontaneous Report Data

Vaccine Age at event (years): median (Q1–Q3) Female (%) Year of reporting: median (Q1, Q3) Number (%) of spontaneous reports Number of countries
Engerix ™ 31.0 (18.0, 43.0) 64.2 1999 (1993, 2005) 34,347 (23.4 %) 92
Havrix™ 23.0 (11.0, 40.0) 57.8 2004 (1998, 2007) 9,066 (6.2 %) 58
Cervarix™ 15.0 (12.0, 17.0) 99.5 2009 (2008, 2009) 3,437 (2.3 %) 63
Infanrix™ 5.0 (1.5, 10.0) 45.5 2006 (2003, 2007) 9,732 (6.6 %) 59
Infanrix™ Hib 1.5 (0.8, 1.9) 42.5 2002 (1999, 2003) 1,027 (0.7 %) 21
Rotarix™ 0.3 (0.2, 0.6) 46.3 2008 (2007, 2009) 2,800 (1.9 %) 73
Fluarix™ 41.0 (19.0, 60.0) 60.0 2005 (2002, 2007) 6,864 (4.7 %) 69
Twinrix™ 31.0 (19.0, 45.0) 57.6 2006 (2003, 2008) 9,836 (6.7 %) 51